RNA Therapeutics 2021
Event Feb 11 - Feb 11, 2020
Copthorne Tara Hotel, Kensington
Scarsdale Pl, Kensington, London W8 5SY London, UK
RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy personalised medicines, and treatment of genetic, infectious and chronic diseases. This is reflected with the value of the global antisense & RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%. Furthermore, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, have triggered a major expansion of the RNA-therapeutics field.
The 2021 conference is set to explore the latest developments in RNA delivery agents and RNA-based therapeutics with the latest case studies on advanced mRNA technologies, oligonucleotide delivery, therapeutic applications and future trends and innovations.
Join us in February 2021, as SMi’s 12th annual RNA Therapeutics Conference brings together industry experts from leading RNA therapeutics companies to gain an expert and holistic view on the latest developments in the industry, upcoming regulatory updates and industry implications.
BENEFITS OF ATTENDING:
• Explore in industry insights into how mRNA is being used to combat COVID-19
• Engage in case studies exploring the growing therapeutic potential of RNA for rare diseases
• Delve into future trends in AI application for optimal RNA therapeutics
• Hear regulatory outlooks of the RNA landscape, clinical trials and looking ahead
View the full agenda and speaker line-up online: www.therapeutics-rna.com/technetwl
Focus day on RNA Interference – 12TH February 2021
As the industry of RNA therapeutics advances this year’s focus day will explore the growing potential of RNA interference. The focus day will present sessions that explore the evolving approaches to RNAi including: antifibrotic microRNA-based therapeutics for the treatment of Alport syndrome, self-deliverable RNAi and an exploration into how siRNA can be modified for self-delivery, and targeted delivery of nucleic acid therapeutics. Furthermore, this year’s focus day will be highlighting the emerging trends and future outlook of RNAi in the Pharmaceutical industry.
BOOK BY 30TH OCTOBER AND SAVE £400
BOOK BY 30TH NOVEMBER AND SAVE £200
BOOK BY 11TH DECEMBER AND SAVE £100